AMANDA CUNNINGHAM: Open Payments
NPI 1902303514 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 25 payments from 13 companies in 2025. Trend: 2023 $438 · 2024 $473 · 2025 $586
Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $151 |
| Novo Nordisk Inc | 5 | $98 |
| ABBVIE INC. | 3 | $59 |
| PFIZER INC. | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $36 |
| CSL Behring | 1 | $31 |
| Astellas Pharma US Inc | 1 | $29 |
| Lilly USA, LLC | 1 | $21 |
| Grifols USA, LLC | 1 | $21 |
Products named: TEZSPIRE, Ozempic, NURTEC ODT, Kerendia, AIRSUPRA, UBRELVY, CUVITRU, Andembry.
Industry payments across GA — which companies pay providers there.
